Enter filer or issuer name and time period and form type to see Ownership filings.
Submit
Enter Mutual Fund name or ticker and time period and form type to see company Mutual Fund.
Submit
 

BRIGGS & STRATTON CORP BGGSQ

Date Filed : Sep 16, 2020

Period Ended : Sep 15, 2020

Click here be alerted whenever BRIGGS & STRATTON CORP [BGGSQ] files 8-K
bgg-20200915
0000014195 FALSE 0000014195 2020-09-15 2020-09-15 0000014195 2020-07-20 2020-07-20

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM 8-K
 
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
 
 
Date of Report (Date of earliest event reported):  September 15, 2020
 
BRIGGS & STRATTON CORPORATION
(Exact name of registrant as specified in its charter)
 

Wisconsin   1-1370   39-0182330
(State or other jurisdiction (Commission (I.R.S. Employer
 of incorporation) File Number)    Identification No.)

12301 West Wirth Street , Wauwatosa , Wisconsin 53222
(Address of Principal Executive Offices) (Zip Code)

Registrant’s telephone number, including area code ( 414 259-5333


        Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):

 Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act*:
Title of each class Trading Symbol Name of each exchange on which registered
Common Stock (par value $0.01 per share) BGGSQ N/A
* On August 4, 2020, a Form 25 relating to the delisting and deregistration under Section 12(b) of the Act of the registrant’s common stock was filed by the New York Stock Exchange. The registrant’s common stock trades on the OTC Pink Market.

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company    




If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.     o


BRIGGS & STRATTON CORPORATION AND SUBSIDIARIES
Item 7.01 Regulation FD Disclosure.

As previously disclosed, on July 20, 2020, Briggs & Stratton Corporation (the “Company”) and certain of its subsidiaries (collectively, the “Debtors”) filed voluntary petitions (the “Chapter 11 Cases”) for relief under chapter 11 of title 11 of the United States Code (the “Bankruptcy Code”) in the United States Bankruptcy Court for Eastern District of Missouri (the “Bankruptcy Court”) . On September 15, 2020, the Bankruptcy Court approved the sale of substantially all of the assets of the Debtors pursuant to Section 363 of the Bankruptcy Code (the “Sale”). The closing of the Sale is subject to customary closing obligations and is expected to occur shortly hereafter, or, in any case, no later than the end of September. As previously disclosed in a Form 12b-25 filed on September 14, 2020 with the Securities and Exchange Commission, the Company expects that no proceeds from the Sale will be distributed to the Company’s shareholders.

The Company expects that equity holders will experience a complete loss of their investment and therefore cautions against trading in the Company’s equity securities.

Cautionary Statement on Forward-Looking Statements

Various statements in this Current Report on Form 8-K, including those that express a belief, expectation or intention, as well as those that are not statements of historical fact, are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The Company’s actual results may differ materially from those anticipated in these forward-looking statements as a result of certain risks and other factors, which include the following: risks and uncertainties relating to the Chapter 11 Cases, including but not limited to, the timing of the closing of the Sale, the Company’s ability to obtain Bankruptcy Court approval with respect to motions in the Chapter 11 Cases, the effects of the Chapter 11 Cases on the Company and on the interests of various constituents, Bankruptcy Court rulings in the Chapter 11 Cases and the outcome of the Chapter 11 Cases in general, the duration of the Chapter 11 Cases, risks associated with third-party motions in the Chapter 11 Cases, and the Company’s ability to realize proceeds from remaining assets; risks related to the trading of the Company’s common stock on the OTC Pink Market, particularly because the proposed plan of liquidation provides that there will not be sufficient funds or other assets to allow holders of the Company’s common stock to receive any distribution of value in respect of their equity interests; risks relating to the Company’s ability to obtain Bankruptcy Court confirmation of the proposed plan of liquidation as proposed by the Company; the uncertainty as to when or whether the effective date of the proposed plan of liquidation will occur as currently expected by the Company; and the risk that the Chapter 11 Cases may be converted to cases under chapter 7 of the Bankruptcy Code. The Company therefore cautions readers against relying on these forward-looking statements. All forward-looking statements attributable to the Company or persons acting on the Company’s behalf are expressly qualified in their entirety by the foregoing cautionary statements. All such statements speak only as of the date made, and, except as required by law, the Company undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise.





2

BRIGGS & STRATTON CORPORATION AND SUBSIDIARIES

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
        
  BRIGGS & STRATTON CORPORATION
  (Registrant)
Date: September 16, 2020   /s/ Mark A. Schwertfeger
  Mark A. Schwertfeger
  Senior Vice President and Chief Financial Officer
Duly Authorized Officer


3
Logo

Crocs, Inc. Appoints Charisse Ford Hughes to Board of Directors

Crocs, Inc. (NASDAQ: CROX), a global leader in casual footwear for women, men and children today ann...

Logo

Splunk Names New Chief Customer and Chief Revenue Officers

Splunk Inc. (NASDAQ: SPLK), provider of the Data-to-Everything Platform, today announced that it has...

Logo

Diodes Incorporated Receives Approval from China’s Antitrust Authority for Lite-On Semiconductor Acquisition

Diodes Incorporated (Nasdaq: DIOD) today announced the Company has received approval from the China’...

Logo

COSTCO WHOLESALE CORPORATION REPORTS FOURTH QUARTER AND FISCAL YEAR 2020 OPERATING RESULTS

Costco Wholesale Corporation (“Costco” or the “Company”) (Nasdaq: COST) today announced its operatin...

Logo

The First Bancorp Declares Third Quarter Dividend

The Board of Directors of The First Bancorp (NASDAQ: FNLC), the parent company of First National Ban...

Logo

Telos Corporation Welcomes TAPS Founder and President Bonnie Carroll to its Board of Directors

Telos® Corporation, a leading provider of cyber, cloud and enterprise security solutions for t...

Loading...